163 related articles for article (PubMed ID: 32052244)
1. HCV infection and non-Hodgkin lymphomas: an evolving story.
Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L
Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M; Carli G; Arcaini L; Visco C
World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
[TBL] [Abstract][Full Text] [Related]
3. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.
Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F
Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
5. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
[TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of HCV-associated B-Cell Non-Hodgkin Lymphomas With Direct-acting Antiviral Agents.
de Clerck F; Geerts A; Brochez L; Speeckaert R; Boterberg T; Van Vlierberghe H; Verhelst X
J Clin Gastroenterol; 2016; 50(5):438. PubMed ID: 26905607
[No Abstract] [Full Text] [Related]
8. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
Kelaidi C; Rollot F; Park S; Tulliez M; Christoforov B; Calmus Y; Podevin P; Bouscary D; Sogni P; Blanche P; Dreyfus F
Leukemia; 2004 Oct; 18(10):1711-6. PubMed ID: 15284859
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
Arcaini L; Bruno R
Curr Clin Pharmacol; 2010 May; 5(2):74-81. PubMed ID: 20156155
[TBL] [Abstract][Full Text] [Related]
10. Antiviral therapies for managing viral hepatitis in lymphoma patients.
Merli M; Rattotti S; Gotti M; Arcaini L
Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.
Visco C; Finotto S
World J Gastroenterol; 2014 Aug; 20(32):11054-61. PubMed ID: 25170194
[TBL] [Abstract][Full Text] [Related]
12. From hepatitis C virus infection to B-cell lymphoma.
Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus - Associated marginal zone lymphoma.
Armand M; Besson C; Hermine O; Davi F
Best Pract Res Clin Haematol; 2017; 30(1-2):41-49. PubMed ID: 28288715
[TBL] [Abstract][Full Text] [Related]
15. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy.
Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J
Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334
[TBL] [Abstract][Full Text] [Related]
16. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.
Arcaini L; Vallisa D; Rattotti S; Ferretti VV; Ferreri AJM; Bernuzzi P; Merli M; Varettoni M; Chiappella A; Ambrosetti A; Tucci A; Rusconi C; Visco C; Spina M; Cabras G; Luminari S; Tucci M; Musto P; Ladetto M; Merli F; Stelitano C; d'Arco A; Rigacci L; Levis A; Rossi D; Spedini P; Mancuso S; Marino D; Bruno R; Baldini L; Pulsoni A
Ann Oncol; 2014 Jul; 25(7):1404-1410. PubMed ID: 24799461
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin lymphoma and hepatitis C: where we are and what next?
Sulyok M; Makara M; Újhelyi E; Vályi-Nagy I
Pathol Oncol Res; 2015 Jan; 21(1):1-7. PubMed ID: 25273531
[TBL] [Abstract][Full Text] [Related]
18. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and lymphoma.
Paydas S
Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
[TBL] [Abstract][Full Text] [Related]
20. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
Hermine O; Lefrère F; Bronowicki JP; Mariette X; Jondeau K; Eclache-Saudreau V; Delmas B; Valensi F; Cacoub P; Brechot C; Varet B; Troussard X
N Engl J Med; 2002 Jul; 347(2):89-94. PubMed ID: 12110736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
